Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11597768 Immunotherapy for hepatocellular carcinoma

Patent 11597768 was granted and assigned to BeiGene, Ltd on March, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 2 Oct, 2024

"update inverses"

edited on 2 Oct, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 12103931 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

0

Edits on 6 Jun, 2024

"update inverses"

edited on 6 Jun, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11999743 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

0

Edits on 1 May, 2024

"update inverses"

edited on 1 May, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11970500 Crystalline form of (s)-7-(1-acryloylpiperidin-4-yl)- 2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

0

Edits on 1 Feb, 2024

"update inverses"

edited on 1 Feb, 2024

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11884674 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra- hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

0

Edits on 27 Dec, 2023

"update inverses"

edited on 27 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

US Patent 11851437 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

0

Edits on 29 Apr, 2023

"update citations for inverse infoboxes"

edited on 29 Apr, 2023

Infobox

Patent Citations

US Patent 10005782 Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators

0

Edits on 28 Apr, 2023

"update citations for inverse infoboxes"

edited on 28 Apr, 2023

Infobox

Patent Citations

US Patent 10864203 Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer

0

Edits on 28 Apr, 2023

"update citations for inverse infoboxes"

edited on 28 Apr, 2023

Infobox

Patent Citations

US Patent 11202782 Treatment cancers using a combination comprising PARP inhibitors

0

"update citations for inverse infoboxes"

edited on 27 Apr, 2023

Infobox

Patent Citations

US Patent 10519235 Anti-PD1 antibodies and their use as therapeutics and diagnostics

0

"update citations for inverse infoboxes"

edited on 27 Apr, 2023

Infobox

Patent Citations

US Patent 10858435 PD1 binding agents

0

Edits on 3 Apr, 2023

"update citations for inverse infoboxes"

edited on 3 Apr, 2023

Infobox

Patent Citations

US Patent 10927117 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

0

Edits on 31 Mar, 2023

"update citations for inverse infoboxes"

edited on 31 Mar, 2023

Infobox

Patent Citations

US Patent 10058609 Antigen binding proteins that bind PD-L1

0

Edits on 28 Mar, 2023

"Entity importer update"

edited on 28 Mar, 2023

Infobox

Is a

0

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

115977680

Date of Patent

March 7, 2023

0

Patent Application Number

166213420

Date Filed

June 26, 2018

0

Patent Citations

US Patent 11186637 Anti-PD1 antibodies and their use as therapeutics and diagnostics

0

US Patent 11202782 Treatment cancers using a combination comprising PARP inhibitors

0

US Patent 11203637 Anti-Tim-3 antibodies and use thereof

0

US Patent 10005782 Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators

0

US Patent 10058609 Antigen binding proteins that bind PD-L1

0

US Patent 10487147 Anti-PD-L1 antibodies and uses thereof

0

US Patent 10519235 Anti-PD1 antibodies and their use as therapeutics and diagnostics

0

US Patent 10544225 Anti-PD-L1 antibodies and their use as therapeutics and diagnostics

0

US Patent 10550185 Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments

0

US Patent 10570139 Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators

0

US Patent 10793632 Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors

0

US Patent 10858435 PD1 binding agents

0

US Patent 10864203 Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer

0

US Patent 10927117 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

0

Patent Primary Examiner

Nelson B Moseley, II

0

CPC Code

0

0

0

0

0

0

0

0

0

0

"update citations for inverse infoboxes"

edited on 28 Mar, 2023

Infobox

Patent Citations

US Patent 10544225 Anti-PD-L1 antibodies and their use as therapeutics and diagnostics

0

Edits on 25 Mar, 2023

"update citations for inverse infoboxes"

edited on 25 Mar, 2023

Infobox

Patent Citations

US Patent 10550185 Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments

0

Edits on 8 Mar, 2023

"Created via: Entity Importer"

created this topic on 8 Mar, 2023

Edits made to:

Infobox (+33 properties)

Article (+335 characters)

‌

US Patent 11597768 Immunotherapy for hepatocellular carcinoma

Article

Disclosed herein is method for the prevention, delay of progression or treatment of hepatocellular carcinoma in a subject, comprising administering to the subject in need thereof a therapeutically effective amount of an anti-PD-1 antibody, which is an antibody or a fragment antigen binding thereof, specifically binding to human PD-1.

Infobox

Is a

0

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

115977680

Date of Patent

March 7, 2023

0

Patent Application Number

166213420

Date Filed

June 26, 2018

0

Patent Citations

US Patent 11186637 Anti-PD1 antibodies and their use as therapeutics and diagnostics

0

US Patent 11202782 Treatment cancers using a combination comprising PARP inhibitors

0

US Patent 11203637 Anti-Tim-3 antibodies and use thereof

0

US Patent 10005782 Substituted pyrazolo[1,5-a]pyrimidines as bruton's tyrosine kinase modulators

0

US Patent 10058609 Antigen binding proteins that bind PD-L1

0

US Patent 10487147 Anti-PD-L1 antibodies and uses thereof

0

US Patent 10519235 Anti-PD1 antibodies and their use as therapeutics and diagnostics

0

US Patent 10544225 Anti-PD-L1 antibodies and their use as therapeutics and diagnostics

0

US Patent 10550185 Bispecific heterodimeric fusion proteins containing IL-15-IL-15Rα Fc-fusion proteins and PD-1 antibody fragments

0

US Patent 10570139 Substituted pyrazolo[1,5-a]pyrimidines as Bruton's tyrosine kinase modulators

0

US Patent 10793632 Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors

0

US Patent 10858435 PD1 binding agents

0

US Patent 10864203 Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer

0

US Patent 10927117 Crystalline form of (S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetra-hydropyrazolo[1,5-a]pyrimidine-3-carboxamide, preparation, and uses thereof

0

Patent Primary Examiner

Nelson B Moseley, II

0

CPC Code

0

0

0

0

0

0

0

0

0

0

Find more entities like US Patent 11597768 Immunotherapy for hepatocellular carcinoma

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool